Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160)
10/2005
10/06/2005WO2005092317A1 Thyroid receptor agonists
10/06/2005US20050222423 Carboxylic acid derivative
10/06/2005US20050222369 Novel sulfurized phenolic resin, process for producing the same, phenol derivative having thioeter structure or disulfide structure, process for producing the same, and epoxy resin composition and adhesive
10/06/2005US20050222254 Sulfonamide compounds for the treatment of neurodegenerative disorders
10/06/2005US20050222253 Anti-cancer nitro- and thia-fatty acids
10/06/2005US20050222243 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/06/2005US20050222213 Alpha(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
10/06/2005US20050222083 Thiol-modified hyaluronan
10/06/2005US20050221211 Organophotoreceptors suitable for use in electrophotography
10/06/2005US20050218532 higher reactivity with an electrophile; lithium chloride complexes; using organometallic R1(MgX).LiY, a fast exchange reaction occurs leading to Grignard reagents in high yields under mild conditions; ether solvent; phenyl-(4-cyanophenyl)methanol from benzaldehyde, 4-bromobenzonitrile and i-PrMgCl.LiCl
10/06/2005CA2562633A1 Thyroid receptor agonists
10/06/2005CA2560392A1 Surface treating agent, fluorine-containing monomer and fluorine-containing polymer
10/06/2005CA2560388A1 Fluorine-containing monomer, fluorine-containing polymer and surface treating agent
10/06/2005CA2559035A1 Substituted heteroaryl- and phenylsulfamoyl compounds
10/06/2005CA2557794A1 Opioid receptor antagonists
10/05/2005EP1582523A1 Method of preparing organomagnesium compounds
10/05/2005EP1581488A1 Inhibitors of tace
10/05/2005EP1097131B1 Method for separating hydroxymethylthiobutyric acid
10/05/2005EP0775110B1 Arylthio compounds as antibacterial and antiviral agents
10/05/2005CN1677250A Poly(azine)-based charge transport materials
10/05/2005CN1221526C Novel phenyl-propargyl ether derivatives
10/05/2005CN1221524C Diphenyl ether compounds useful in therapy
10/05/2005CN1221514C Intermediate for preparing alkyl-dihalogeno phenyl substituted keto-enol
10/04/2005US6951961 Methods of use and compositions for the diagnosis and treatment of infectious disease
10/04/2005US6951945 Heteroaromatic glucokinase activators
10/04/2005US6951887 Lipoic acid derivatives and their use in treatment of disease
10/04/2005US6951860 Such as S-(4-methoxybenzyl)-N-(2-(N',N'-dimethylamino)ethyl) thiosalicylamide; for treatment of cardiovascular disorders
09/2005
09/29/2005WO2005090343A1 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
09/29/2005WO2005089269A2 Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders
09/29/2005US20050215819 Method of producing an amide
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005US20050215637 Tuberculosis treatment
09/29/2005US20050215630 3-Phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha
09/29/2005US20050215598 Phenylalanine derivatives
09/29/2005US20050215590 Formamide derivatives for the treatment of diseases
09/29/2005US20050214853 Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter
09/29/2005CA2557896A1 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
09/28/2005EP1579874A2 Conjugate having a cleavable linkage for use in a liposome
09/28/2005EP1578898A2 Nad synthetase inhibitors and uses thereof
09/28/2005EP1578725A1 Microsomal triglyceride transfer protein inhibitors
09/28/2005EP1578716A1 Dicarboxylic acid derivatives as ppar-agonists
09/28/2005EP1578353A2 Methods of use and compositions for the diagnosis and treatment of infectious disease
09/28/2005EP1265838B1 Novel fatty acid analogous
09/28/2005EP1093453B1 Naaladase inhibitors useful as pharmaceutical compounds and compositions
09/28/2005CN1675229A Sulfur-containing phospholipid derivatives
09/28/2005CN1675171A Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
09/28/2005CN1675168A Propionic acid derivatives and their use as hPPARs activators
09/28/2005CN1675154A Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF)
09/28/2005CN1674897A Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as HPPAR activators
09/28/2005CN1674885A Methods for treatment and prevention of gastrointestinal conditions
09/28/2005CN1674883A Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
09/27/2005US6949678 For resist applications; thermostability, storage stability
09/27/2005US6949663 Multilayer; anticoagulant
09/27/2005US6949567 Asymmetric amidine-substituted diphenylureas; diseases treated by the inhibition of intracellular protein degradation pathways, e.g. proteases, proteasome; anticarcinogenic agents; immunological modulators
09/27/2005US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders
09/27/2005US6949530 Hypotensive agents
09/27/2005US6949516 Oligopeptides used as antiapoptosis agents
09/27/2005CA2193337C 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
09/27/2005CA2122346C Bistriazenes as chemotherapeutic agents
09/22/2005WO2005087717A1 Integrin modulators and methods for their use
09/22/2005WO2005087710A1 Aminophenylpropanoic acid derivative
09/22/2005WO2005087700A2 Bisphenyl compounds useful as vitamin d3 receptor agonists
09/22/2005WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005WO2005037208A3 Nitrone compounds prodrugs and pharmaceutical compositions of the same to treat human disorders
09/22/2005US20050209488 Reacting 1-amino-2-hydroxy-indene with a first protecting group containing a leaving group, followed by acetylation to prepare a protected intermediate, reacting with trifluoromethyl substituted ketone, then with metal oxide, hydrolysis, esterification, reaction with amino-picoline
09/22/2005US20050209462 Synthesis of benzimidate from benzoic acid
09/22/2005US20050209323 Malononitrile compounds and their use as pesticides
09/22/2005US20050209320 Compounds comprise an androgen receptor (AR) binding moiety which selectively targets the compounds to AR-expressing cancer cells, and a cytotoxic alkylating moiety, such as a nitrogen mustard moiety; (2R)-2-hydroxy-3-[(4-hydroxyphenyl)thio]-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
09/22/2005US20050209275 Beta 2-adrenergic receptor agonists
09/22/2005US20050208480 aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies
09/22/2005US20050208402 Electrophotographic photosensitive member, process cartridge and electrophotographic apparatus
09/22/2005US20050208015 Glycerol derivative
09/22/2005CA2560111A1 Aminophenylpropanoic acid derivative
09/22/2005CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/21/2005EP1577310A1 Processes for producing optically active 2-thiomethyl-3-phenylpropionic acid derivative and for producing intermediate therefor
09/21/2005EP1577291A1 Phenylethanolamine derivatives as beta-2 agonists
09/21/2005EP1577288A1 Selective estrogen receptor modulators
09/21/2005EP1575911A2 Biaromatic compounds which activate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions
09/21/2005EP1575903A1 Compounds for the inhibition of rotamases
09/21/2005EP1575900A1 N-methyl amino acids
09/21/2005EP1575495A2 Compounds and methods
09/21/2005EP1294679B1 Beta-amino acid nitrile derivatives
09/21/2005EP1282602B1 Propanoic acid derivatives as integrin receptor antagonists
09/21/2005CN1671657A Method for synthesis of hydrogenofluoromethylenesulphonyl radical derivatives
09/21/2005CN1671656A Process for the preparation of thioalkylamine derivatives
09/21/2005CN1671655A Novel phthalamide derivatives
09/21/2005CN1671651A N-bisaryl- and N-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides
09/21/2005CN1219759C Intermediate for preparing substitated biphenyl oxazoline compounds
09/20/2005US6946491 such as 3-[(4-(2-fluorobenzyloxy)phenyl)-methylthio]propionic acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
09/20/2005US6946471 2-(2,6-Dichlorophenyl)-Diarylimidazoles
09/20/2005CA2097676C 2,2-dimethyl 3[(z)1-propenyl] cyclopropane carboxylic acid and intermediates, and process for its preparation
09/15/2005WO2005085216A1 Isoxazoline-substituted benzamide compound and noxious organism control agent
09/15/2005WO2004111086A3 Peptide analogues comprising at least one type of aminoacyl aza-$g(b)3 and the use thereof, in particular for therapy
09/15/2005US20050203149 Alkanamide alpha-monohydrazone derivatives, e.g., N-(4-chlorobenzyl)-2-(4-trifluoromethylphenylhydrazono)propionamide, for agricultural and horticultural use, clothing, food and housing-related use, or livestock and pet use
09/15/2005US20050203108 Glucagon antagonists/inverse agonists
09/15/2005US20050203096 Compounds to treat Alzheimer's disease
09/15/2005CA2558848A1 Isoxazoline-substituted benzamide compound and pesticide
09/14/2005EP1572655A2 Novel arylheteroalkylamine derivatives
09/14/2005EP1572637A1 Novel mch receptor antagonists
09/14/2005EP1572068A2 Arylheteroalkalylamine derivatives and their use as inhibitors of nitric oxide synthase
1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 272